BNP Paribas Financial Markets’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.66M Buy
204,866
+100,280
+96% +$811K ﹤0.01% 1948
2025
Q1
$876K Sell
104,586
-63,608
-38% -$533K ﹤0.01% 2121
2024
Q4
$1.33M Buy
168,194
+113,796
+209% +$901K ﹤0.01% 1914
2024
Q3
$453K Sell
54,398
-402,852
-88% -$3.35M ﹤0.01% 2204
2024
Q2
$2.9M Buy
457,250
+358,058
+361% +$2.27M ﹤0.01% 1179
2024
Q1
$601K Buy
99,192
+38,031
+62% +$230K ﹤0.01% 2120
2023
Q4
$371K Sell
61,161
-20,106
-25% -$122K ﹤0.01% 2272
2023
Q3
$343K Buy
81,267
+15,548
+24% +$65.6K ﹤0.01% 2247
2023
Q2
$204K Sell
65,719
-56,875
-46% -$176K ﹤0.01% 2398
2023
Q1
$170K Buy
122,594
+42,053
+52% +$58.5K ﹤0.01% 2575
2022
Q4
$160K Sell
80,541
-6,598
-8% -$13.1K ﹤0.01% 2435
2022
Q3
$176K Sell
87,139
-22,379
-20% -$45.2K ﹤0.01% 2853
2022
Q2
$348K Sell
109,518
-26,492
-19% -$84.2K ﹤0.01% 2235
2022
Q1
$567K Sell
136,010
-31,615
-19% -$132K ﹤0.01% 2143
2021
Q4
$803K Buy
167,625
+105,925
+172% +$507K ﹤0.01% 2155
2021
Q3
$329K Buy
61,700
+24,756
+67% +$132K ﹤0.01% 2324
2021
Q2
$189K Sell
36,944
-9,035
-20% -$46.3K ﹤0.01% 2296
2021
Q1
$309K Sell
45,979
-5,660
-11% -$38.1K ﹤0.01% 2296
2020
Q4
$236K Sell
51,639
-2,185
-4% -$9.99K ﹤0.01% 2174
2020
Q3
$209K Sell
53,824
-167,218
-76% -$649K ﹤0.01% 2145
2020
Q2
$1.05M Buy
221,042
+152,103
+221% +$724K ﹤0.01% 1288
2020
Q1
$240K Buy
68,939
+20,386
+42% +$70.9K ﹤0.01% 2183
2019
Q4
$234K Sell
48,553
-1,687
-3% -$8.13K ﹤0.01% 2247
2019
Q3
$146K Buy
50,240
+37,686
+300% +$109K ﹤0.01% 2300
2019
Q2
$90K Sell
12,554
-7,873
-39% -$56.4K ﹤0.01% 2486
2019
Q1
$289K Buy
20,427
+18,062
+764% +$256K ﹤0.01% 1912
2018
Q4
$32K Sell
2,365
-2,978
-56% -$40.3K ﹤0.01% 2263
2018
Q3
$119K Buy
5,343
+586
+12% +$13K ﹤0.01% 2008
2018
Q2
$78.1K Buy
+4,757
New +$78.1K ﹤0.01% 2283